Operating
Impairment Charges
Year-over-year, this metric grew by 100.0%, from -$276.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalLower is better
VolatilityVolatile
First reportedQ1 2015
Last reportedQ4 2025
How to read this metric
High impairment charges suggest poor capital allocation or a decline in the competitive value of the company's assets.
Detailed definition
Impairment charges are non-cash write-downs taken when the carrying value of an asset exceeds its fair market value. Thi...
Peer comparison
Common in industries with high intangible asset bases, such as pharma and consumer goods.
Metric ID:
cf_impairment_chargesHistorical Data
15 periods
| Q3 '21 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $571.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $485.00M | $246.00M | $115.00M | $268.00M | -$276.00M | -$699.00M | -$99.00M | $0.00 | $0.00 |
| QoQ Change | — | -100.0% | — | — | — | — | — | -49.3% | -53.3% | +133.0% | -203.0% | -153.3% | +85.8% | +100.0% | — |
| YoY Change | — | -100.0% | — | — | — | — | — | — | — | — | -156.9% | -384.1% | -186.1% | -100.0% | +100.0% |
Range-$699.00M – $571.00M
CAGR-100.0%
Avg YoY Growth-137.9%
Median YoY Growth-128.5%
Current Streak3 quarters growth
Impairment Charges at Other Companies
Frequently Asked Questions
- What is Newmont's impairment charges?
- Newmont (NEM) reported impairment charges of $0.00 in Q1 2026.
- How has Newmont's impairment charges changed year-over-year?
- Newmont's impairment charges increased by 100.0% year-over-year, from -$276.00M to $0.00.
- What does impairment charges mean?
- A non-cash charge taken when an asset is determined to be worth less than its recorded value.